Participants 130 157 3
after renal transplantation
Participants 466 477 12
38 patients
Participants 885 946 3
Thirty-six out of 38 (94.7%) recipients were CMV-seropositive
Participants 993 1060 4
13 episodes of CMV disease in eight (66.7%) patients of the C group
